Accolade (NASDAQ:ACCD) Issues Earnings Results

Accolade (NASDAQ:ACCD) announced its earnings results on Wednesday. The company reported ($0.32) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.03, MarketWatch Earnings reports. The firm had revenue of $38.44 million during the quarter, compared to analysts’ expectations of $36.20 million. Accolade’s revenue for the quarter was up 29.7% compared to the same quarter last year.

NASDAQ ACCD opened at $49.67 on Friday. Accolade has a twelve month low of $28.68 and a twelve month high of $65.25. The business’s 50 day moving average price is $50.48.

ACCD has been the topic of several research reports. DA Davidson boosted their price target on shares of Accolade from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Thursday, October 15th. BTIG Research initiated coverage on shares of Accolade in a research report on Wednesday. They issued a “buy” rating and a $55.00 price target on the stock. Canaccord Genuity initiated coverage on shares of Accolade in a research report on Tuesday, December 8th. They issued a “buy” rating and a $59.00 price target on the stock. Robert W. Baird boosted their price target on shares of Accolade from $45.00 to $50.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, Piper Sandler boosted their price target on shares of Accolade from $55.00 to $57.00 and gave the stock an “overweight” rating in a research report on Friday. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Accolade has a consensus rating of “Buy” and an average target price of $50.08.

About Accolade

Accolade, Inc develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.

Recommended Story: Market Capitalization and Individual Investors

Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit